Cardio Diagnostics Holdings Inc’s recently made public that its Chief Medical Officer Philibert Robert acquired Company’s shares for reported $9763.0 on Sep 06 ’24. In the deal valued at $0.29 per share,34,075 shares were bought. As a result of this transaction, Philibert Robert now holds 1,683,867 shares worth roughly $0.32 million.
Then, Dogan Meeshanthini bought 68,965 shares, generating $20,000 in total proceeds. Upon buying the shares at $0.29, the Chief Technology Officer now owns 197,310 shares.
Before that, Dogan Meeshanthini bought 68,965 shares. Cardio Diagnostics Holdings Inc shares valued at $20,000 were divested by the Chief Executive Officer at a price of $0.29 per share. As a result of the transaction, Dogan Meeshanthini now holds 1,683,867 shares, worth roughly $0.32 million.
Price Performance Review of CDIO
On Friday, Cardio Diagnostics Holdings Inc [NASDAQ:CDIO] saw its stock fall -12.85% to $0.19. Over the last five days, the stock has lost -56.69%. Cardio Diagnostics Holdings Inc shares have fallen nearly -79.81% since the year began. Nevertheless, the stocks have fallen -74.31% over the past one year. While a 52-week high of $1.77 was reached on 01/06/25, a 52-week low of $0.18 was recorded on 05/09/25. SMA at 50 days reached $0.4021, while 200 days put it at $0.4455.
Levels Of Support And Resistance For CDIO Stock
The 24-hour chart illustrates a support level at 0.1713, which if violated will result in even more drops to 0.1574. On the upside, there is a resistance level at 0.2077. A further resistance level may holdings at 0.2302. The Relative Strength Index (RSI) on the 14-day chart is 30.29, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1425, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.72%. Stochastics %K at 8.89% indicates the stock is a buying.
